Ben Haas practices in Latham & Watkins’ Washington, D.C. office, where he is a corporate partner in the Healthcare & Life Sciences Practice. Mr. Haas focuses his practice on regulatory, transactional and legislative matters involving the medical device, pharmaceutical, biotechnology, tobacco, food, cosmetic and dietary supplement industries. Mr. Haas has counseled clients on a wide variety of regulatory matters involving the US Food and Drug Administration (FDA), including, among others:

Pre-market product development and clinical and pre-clinical testing FDA submissions Product promotion and labeling Compliance with good manufacturing practice requirements Agency inspections and recalls

Corporate Partner